NEUROLEPTIC MALIGNANT SYNDROME AND LETHAL CATATONIA

被引：5
|
作者：
LINDESAY, J
机构：
来源：
BRITISH JOURNAL OF PSYCHIATRY | 1986年 / 148卷
关键词：
D O I：
10.1192/bjp.148.3.342
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：342 / 343
页数：2
相关论文
共 50 条
  • [21] CATATONIA AND NEUROLEPTIC MALIGNANT SYNDROME
    Lee, J.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2014, 48 : 94 - 95
  • [22] CATATONIA AND NOT NEUROLEPTIC MALIGNANT SYNDROME
    SWARTZ, CM
    BRITISH JOURNAL OF PSYCHIATRY, 1993, 162 : 274 - 275
  • [23] CLINICAL-DIFFERENTIATION BETWEEN LETHAL CATATONIA AND NEUROLEPTIC MALIGNANT SYNDROME - REPLY
    RUBIN, RT
    AMERICAN JOURNAL OF PSYCHIATRY, 1989, 146 (09): : 1241 - 1242
  • [24] Malignant Catatonia Versus Neuroleptic Malignant Syndrome
    Desai, Saral
    Hirachan, Tinu
    Toma, Anca
    Gerolemou, Adela
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [25] Malignant catatonia and neuroleptic malignant syndrome: Revisited
    Otani, Koichi
    Hayashi, Hiroshi
    Suzuki, Akihito
    Aoshima, Toshiaki
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (06): : 1184 - 1185
  • [26] Treating neuroleptic malignant syndrome as catatonia
    Fink, M
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (01) : 121 - 122
  • [27] CATATONIA - HARBINGER OF THE NEUROLEPTIC MALIGNANT SYNDROME
    WHITE, DAC
    ROBINS, AH
    BRITISH JOURNAL OF PSYCHIATRY, 1991, 158 : 419 - 421
  • [28] NEUROLEPTIC-INDUCED CATATONIA - NEUROLEPTIC MALIGNANT SYNDROME
    DELEON, J
    SAIZRUIZ, J
    ALONSOABOLAFIA, A
    PICOSOLER, E
    MUNOZRUATA, J
    DELASERNA, I
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1990, 14 (01): : 129 - 136
  • [29] Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia
    Fink, Max
    Taylor, Michael Alan
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (06): : 1182 - 1183
  • [30] Neuroleptic-induced catatonia and neuroleptic malignant syndrome
    Lee, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 98 - 99
12345